lifestyle.utv.ie

Author: Aspire Biopharma Holdings, Inc.

Aspire Biopharma Announces $5.0 Million Share Repurchase Program

May 4, 2026
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

May 3, 2026
Aspire Biopharma’s Buzz Bomb(TM) Caffeine Company’s Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo

May 3, 2026
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

May 3, 2026
Aspire Biopharma’s Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion

May 3, 2026
Aspire Biopharma’s Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

April 29, 2026
Aspire Biopharma’s Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

April 29, 2026
Aspire Biopharma’s Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

April 28, 2026
Aspire Biopharma’s BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

March 10, 2026
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

March 3, 2026